Lenvatinib

Lenvatinib
Pharmacopoeia IH
Molar Mass 426.853 g/mol
Formula C21H19ClN4O4
Trade Name Lenvima, Lenvanix
Click to view more

Preferred Buyer From

Location All Countries Except India

Product Details

Metabolism
Cyp3a4, Aldehyde Oxidase, Non-enzymatic
Form
Powder

Lenvatinib is an anti-cancer drug for the treatment of certain kinds of thyroid cancer and for other cancers as well. It was developed by Eisai Co. and acts as a multiple kinase inhibitor against the VEGFR1, VEGFR2 and VEGFR3 kinases.

Yes! I am interested

Looking for "Lenvatinib" ?

Explore More Products


Raise your Query

Hi! Simply click below and type your query.

Our experts will reply you very soon.

WhatsApp Us